Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 2, 2015, Pages 1967-1972

  Zhang, Yajun ^a   Li, Hongbing ^a   Han, Jichang ^a   Zhang, Yi Jie ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

Disease free survival; MiR 124; Non small cell lung cancer; Overall survival

Indexed keywords

MICRORNA; MIRN124 MICRORNA, HUMAN;

DISEASE COURSE; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENETICS; HUMAN; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; SURVIVAL RATE;

EID: 84928150229     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG and Shepherd FA. Non-small-cell lung cancer. Lancet 2011; 378: 1727-1740.
3. He L and Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
4. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
5. Osada H and Takahashi T. MicroRNAs in biological processes and carcinogenesis. Carcinogenesis 2007; 28: 2-12.
6. Esquela-Kerscher A and Slack FJ. Oncomirs-microRNAs with a role in cancer. Nature Rev Cancer 2006; 6: 259-269.
7. Mirnezami A, Pickard K, Zhang L, Primrose J and Packham G. MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol (EJSO) 2009; 35: 339-347.
8. Lee MR, Kim JS and Kim KS. miR-124a is important for migratory cell fate transition during gastrulation of human embryonic stem cells. Stem Cells 2010; 28: 1550-1559.
9. Cheng LC, Pastrana E, Tavazoie M and Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 2009; 12: 399-408.
10. Zhang J, Lu Y, Yue X, Li H, Luo X, Wang Y, Wang K and Wan J. MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. PLoS One 2013; 8: e70300.
11. Hu CB, Li QL, Hu JF, Zhang Q, Xie JP and Deng L. miR-124 inhibits growth and invasion of gastric cancer by targeting ROCK1. Asian Pac J Cancer Prev 2014; 15: 6543-6546.
12. Zhao WH, Wu SQ and Zhang YD. Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L. Int J Mol Med 2013; 32: 101-107.
13. Li L, Luo J, Wang B, Wang D, Xie X, Yuan L, Guo J, Xi S, Gao J, Lin X, Kong Y, Xu X, Tang H and Liu M. Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Mol Cancer 2013; 12: 163.
14. Goldstraw P and Crowley JJ. The International Association for the Study of Lung Cancer international staging project on lung cancer. J Thorac Oncol 2006; 1: 281-286.
15. Haber DA, Bell DW, Sordella R, Kwak EL, Godin-Heymann N, Sharma SV, Lynch TJ and Settleman J. Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors. Cold Spring Harb Symp Quant Biol 2005; 70: 419-426.
16. Nana-Sinkam SP and Croce CM. Clinical applications for microRNAs in cancer. Clin Pharmacol Ther 2013; 93: 98-104.
17. Liu J, Lu KH, Liu ZL, Sun M, De W and Wang ZX. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. BMC Cancer 2012; 12: 519.
18. Zhang J, Xu L, Yang Z, Lu H, Hu D, Li W, Zhang Z, Liu B and Ma S. MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin. Clin Transl Oncol 2014; [Epub ahead of print].
19. Xu T, Liu X, Han L, Shen H, Liu L and Shu Y. Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer. Clin Transl Oncol 2014; 16: 469-475.